The characteristics and risk factors of cerebrovascular events in young systemic lupus erythematosus patients: A case-control study

被引:0
|
作者
Hsu, Uei-Hsiang [1 ]
Lin, Yu-Tsan [2 ]
Chiang, Bor-Luen [2 ,3 ]
机构
[1] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Pediat, Hsinchu, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Pediat, 7 Chung Shan South Rd, Taipei 100, Taiwan
[3] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan
关键词
APS; Cerebrovascular events; Hyperlipidemia; Risk factors; SLE; ANTIPHOSPHOLIPID ANTIBODIES; PRIMARY PREVENTION; REVISED CRITERIA; DISEASE-ACTIVITY; CLASSIFICATION; PREVALENCE; ONSET; THROMBOSIS; HEMORRHAGE; MORBIDITY;
D O I
10.1016/j.jfma.2023.09.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: We clarified the characteristics and risk factors of CVEs in young SLE patients. Method: We retrospectively reviewed the medical records of patients younger than 50 years of age diagnosed with SLE and first CVEs from 1995 to 2020 in a tertiary medical center in Taiwan. We collected data on the patient characteristics before the CVE and reviewed the laboratory data obtained during the period. At a ratio of 1:3, cases and controls were matched with sex, SLE diagnosis age, diagnosis year, and SLE duration. Results: We enrolled 43 CVE SLE patients and matched 129 non-CVE SLE controls. The median age at the time of the CVE was 39 years. Around 70% of young-aged CVE involved the cerebral lobes of frontal (similar to 30%), parietal (similar to 20%), occipital (similar to 10%), and temporal (similar to 10%). The peak incidence period for hemorrhagic CVE was within 1st year of SLE diagnosis (37%); in contrast, during the 2nd to 5th year of SLE diagnosis (25%) for ischemia CVEs. Hyperlipidemia (odds ratio [OR] = 19.36, p = 0.002), anti-phospholipid syndrome (APS) (OR = 41.9, p = 0.0068), a lower hemoglobin level (OR = 0.66, p = 0.0192), and a higher SLE Disease Activity Index (SLEDAI-2k) score (OR = 1.22, p = 0.0019) were independent risk factors for CVEs in young SLE patients. Conclusion: Hyperlipidemia, APS, low Hb level, and high SLEDAI-2k significantly increase the risk of young-aged SLE patients developing CVE. Copyright (c) 2023, Formosan Medical Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/bync-nd/4.0/).
引用
收藏
页码:478 / 486
页数:9
相关论文
共 50 条
  • [1] RISK FACTORS FOR SYSTEMIC LUPUS ERYTHEMATOSUS: CASE-CONTROL STUDY
    Ibragimov, K.
    Axmedov, I.
    Ziyadullayev, S.
    Berdikulov, D.
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S420 - S420
  • [2] Environmental risk factors of systemic lupus erythematosus: a case-control study
    Refai, Rania H.
    Hussein, Mohammed F.
    Abdou, Mamdouh H.
    Abou-Raya, Anna N.
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [3] Prevalence and risk factors for serositis in patients with systemic lupus erythematosus: A case-control study
    Gimeno-Torres, Laura
    Carrion-Barbera, Irene
    Duran, Xavier
    Villegas, Eduardo
    Monfort, Jordi
    Carlos Salman-Monte, Tarek
    [J]. LUPUS, 2021, 30 (13) : 2095 - 2101
  • [4] Hematological malignancies in systemic lupus erythematosus: clinical characteristics, risk factors, and prognosis—a case-control study
    Yuqi Zhang
    Wei Li
    Panpan Zhang
    Jinyan Guo
    Jinlei Sun
    Jiameng Lu
    Shengyun Liu
    [J]. Arthritis Research & Therapy, 24
  • [5] Characteristics and risk factors of pulmonary embolism in patients with systemic lupus erythematosus: a case control study
    You, H.
    Zhao, J.
    Wang, Q.
    Tian, X.
    Li, M.
    Zeng, X.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (05) : 940 - 948
  • [6] Exploring the risk factors for ischemic cerebrovascular disease in systemic lupus erythematosus: A single-center case-control study
    Su, Li
    Qi, Zhigang
    Guan, Shaochen
    Wei, Lian
    Zhao, Yi
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [7] Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden
    Bengtsson, AA
    Rylander, L
    Hagmar, L
    Nived, O
    Sturfelt, G
    [J]. RHEUMATOLOGY, 2002, 41 (05) : 563 - 571
  • [8] RISK-FACTORS FOR THE DEVELOPMENT OF SYSTEMIC LUPUS-ERYTHEMATOSUS - A CASE-CONTROL STUDY
    HOCHBERG, MC
    KASLOW, RA
    [J]. CLINICAL RESEARCH, 1983, 31 (04): : A732 - A732
  • [9] Risk Factors for Neuropsychiatric Manifestations in Children With Systemic Lupus Erythematosus: Case-Control Study
    Zuniga Zambrano, Yenny Carolina
    Guevara Ramos, Juan David
    Penagos Vargas, Nathalia Elena
    Benitez Ramirez, Diana Carol
    Ramirez Rodriguez, Sandra Milena
    Vargas Nino, Adriana Carolina
    Izquierdo Bello, Alvaro Hernando
    [J]. PEDIATRIC NEUROLOGY, 2014, 51 (03) : 403 - 409
  • [10] Osteoporosis and risk factors in women with systemic lupus erythematosus (SLE): A case-control study
    Mok, Chi Chiu
    Ho, Ling Yin
    Yu, Ka Lung
    To, Chi Hung
    Leung, Tung Yeung
    Ma, Kwok Man
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S807 - S807